ARKEMA (AKE.PA) Fundamental Analysis & Valuation

EPA:AKE • FR0010313833

Current stock price

60.85 EUR
+1.3 (+2.18%)
Last:

This AKE.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. AKE.PA Profitability Analysis

1.1 Basic Checks

  • AKE had positive earnings in the past year.
  • AKE had a positive operating cash flow in the past year.
  • AKE had positive earnings in each of the past 5 years.
  • In the past 5 years AKE always reported a positive cash flow from operatings.
AKE.PA Yearly Net Income VS EBIT VS OCF VS FCFAKE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

1.2 Ratios

  • The Return On Assets of AKE (0.27%) is comparable to the rest of the industry.
  • AKE has a Return On Equity (0.57%) which is comparable to the rest of the industry.
  • AKE has a Return On Invested Capital of 1.90%. This is comparable to the rest of the industry: AKE outperforms 40.58% of its industry peers.
  • AKE had an Average Return On Invested Capital over the past 3 years of 2.66%. This is below the industry average of 7.00%.
Industry RankSector Rank
ROA 0.27%
ROE 0.57%
ROIC 1.9%
ROA(3y)1.76%
ROA(5y)4.56%
ROE(3y)3.55%
ROE(5y)8.83%
ROIC(3y)2.66%
ROIC(5y)4.13%
AKE.PA Yearly ROA, ROE, ROICAKE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 0.43%, AKE is in line with its industry, outperforming 47.83% of the companies in the same industry.
  • AKE's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 4.63%, AKE is in line with its industry, outperforming 44.93% of the companies in the same industry.
  • AKE's Operating Margin has declined in the last couple of years.
  • AKE has a Gross Margin of 17.80%. This is in the lower half of the industry: AKE underperforms 73.91% of its industry peers.
  • AKE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.63%
PM (TTM) 0.43%
GM 17.8%
OM growth 3Y-28.32%
OM growth 5Y-8.39%
PM growth 3Y-62.59%
PM growth 5Y-35.51%
GM growth 3Y-7.29%
GM growth 5Y-1.94%
AKE.PA Yearly Profit, Operating, Gross MarginsAKE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. AKE.PA Health Analysis

2.1 Basic Checks

  • AKE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for AKE has been reduced compared to 1 year ago.
  • Compared to 5 years ago, AKE has less shares outstanding
  • The debt/assets ratio for AKE is higher compared to a year ago.
AKE.PA Yearly Shares OutstandingAKE.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
AKE.PA Yearly Total Debt VS Total AssetsAKE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • AKE has an Altman-Z score of 1.76. This is a bad value and indicates that AKE is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 1.76, AKE is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of AKE is 13.85, which is on the high side as it means it would take AKE, 13.85 years of fcf income to pay off all of its debts.
  • AKE has a Debt to FCF ratio of 13.85. This is comparable to the rest of the industry: AKE outperforms 47.83% of its industry peers.
  • A Debt/Equity ratio of 0.56 indicates that AKE is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.56, AKE is in line with its industry, outperforming 44.93% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 13.85
Altman-Z 1.76
ROIC/WACC0.41
WACC4.67%
AKE.PA Yearly LT Debt VS Equity VS FCFAKE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 2.13 indicates that AKE has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 2.13, AKE is doing good in the industry, outperforming 68.12% of the companies in the same industry.
  • AKE has a Quick Ratio of 1.63. This is a normal value and indicates that AKE is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.63, AKE is in the better half of the industry, outperforming 75.36% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 1.63
AKE.PA Yearly Current Assets VS Current LiabilitesAKE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. AKE.PA Growth Analysis

3.1 Past

  • AKE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -47.50%.
  • Measured over the past years, AKE shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.31% on average per year.
  • The Revenue has decreased by -4.99% in the past year.
  • AKE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.84% yearly.
EPS 1Y (TTM)-47.5%
EPS 3Y-34.91%
EPS 5Y-3.31%
EPS Q2Q%-66.14%
Revenue 1Y (TTM)-4.99%
Revenue growth 3Y-7.75%
Revenue growth 5Y2.84%
Sales Q2Q%-7.39%

3.2 Future

  • AKE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.99% yearly.
  • Based on estimates for the next years, AKE will show a small growth in Revenue. The Revenue will grow by 2.68% on average per year.
EPS Next Y14.19%
EPS Next 2Y16.67%
EPS Next 3Y15.04%
EPS Next 5Y11.99%
Revenue Next Year0.21%
Revenue Next 2Y1.55%
Revenue Next 3Y1.99%
Revenue Next 5Y2.68%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
AKE.PA Yearly Revenue VS EstimatesAKE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
AKE.PA Yearly EPS VS EstimatesAKE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

7

4. AKE.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 14.12, AKE is valued correctly.
  • 84.06% of the companies in the same industry are more expensive than AKE, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 26.91. AKE is valued slightly cheaper when compared to this.
  • AKE is valuated correctly with a Price/Forward Earnings ratio of 12.36.
  • Based on the Price/Forward Earnings ratio, AKE is valued cheaper than 81.16% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of AKE to the average of the S&P500 Index (23.68), we can say AKE is valued slightly cheaper.
Industry RankSector Rank
PE 14.12
Fwd PE 12.36
AKE.PA Price Earnings VS Forward Price EarningsAKE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AKE indicates a rather cheap valuation: AKE is cheaper than 89.86% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, AKE is valued cheaply inside the industry as 82.61% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.07
EV/EBITDA 5.55
AKE.PA Per share dataAKE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • AKE's earnings are expected to grow with 15.04% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.99
PEG (5Y)N/A
EPS Next 2Y16.67%
EPS Next 3Y15.04%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. AKE.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 6.19%, AKE is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.35, AKE pays a better dividend. On top of this AKE pays more dividend than 94.20% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, AKE pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.19%

5.2 History

  • The dividend of AKE is nicely growing with an annual growth rate of 10.37%!
Dividend Growth(5Y)10.37%
Div Incr Years4
Div Non Decr Years5
AKE.PA Yearly Dividends per shareAKE.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • 697.44% of the earnings are spent on dividend by AKE. This is not a sustainable payout ratio.
  • The dividend of AKE is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP697.44%
EPS Next 2Y16.67%
EPS Next 3Y15.04%
AKE.PA Yearly Income VS Free CF VS DividendAKE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
AKE.PA Dividend Payout.AKE.PA Dividend Payout, showing the Payout Ratio.AKE.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

AKE.PA Fundamentals: All Metrics, Ratios and Statistics

ARKEMA

EPA:AKE (4/9/2026, 7:00:00 PM)

60.85

+1.3 (+2.18%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners57.22%
Inst Owner ChangeN/A
Ins Owners0.58%
Ins Owner ChangeN/A
Market Cap4.63B
Revenue(TTM)9.07B
Net Income(TTM)39.00M
Analysts72.73
Price Target64.4 (5.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.19%
Yearly Dividend3.59
Dividend Growth(5Y)10.37%
DP697.44%
Div Incr Years4
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-24.85%
Min EPS beat(2)-39.37%
Max EPS beat(2)-10.34%
EPS beat(4)0
Avg EPS beat(4)-16.25%
Min EPS beat(4)-39.37%
Max EPS beat(4)-6.61%
EPS beat(8)2
Avg EPS beat(8)-8.47%
EPS beat(12)5
Avg EPS beat(12)-4.27%
EPS beat(16)9
Avg EPS beat(16)3.1%
Revenue beat(2)1
Avg Revenue beat(2)0.01%
Min Revenue beat(2)-1.17%
Max Revenue beat(2)1.2%
Revenue beat(4)1
Avg Revenue beat(4)-0.34%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)1.2%
Revenue beat(8)2
Avg Revenue beat(8)-0.43%
Revenue beat(12)3
Avg Revenue beat(12)-1.01%
Revenue beat(16)7
Avg Revenue beat(16)-0.03%
PT rev (1m)1.61%
PT rev (3m)0.71%
EPS NQ rev (1m)-15.19%
EPS NQ rev (3m)-32.95%
EPS NY rev (1m)0%
EPS NY rev (3m)-8.24%
Revenue NQ rev (1m)0.55%
Revenue NQ rev (3m)1.16%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-1.21%
Valuation
Industry RankSector Rank
PE 14.12
Fwd PE 12.36
P/S 0.51
P/FCF 14.07
P/OCF 4.64
P/B 0.68
P/tB 2.52
EV/EBITDA 5.55
EPS(TTM)4.31
EY7.08%
EPS(NY)4.92
Fwd EY8.09%
FCF(TTM)4.33
FCFY7.11%
OCF(TTM)13.11
OCFY21.54%
SpS119.22
BVpS89.97
TBVpS24.14
PEG (NY)0.99
PEG (5Y)N/A
Graham Number93.41
Profitability
Industry RankSector Rank
ROA 0.27%
ROE 0.57%
ROCE 3.5%
ROIC 1.9%
ROICexc 2.33%
ROICexgc 4.77%
OM 4.63%
PM (TTM) 0.43%
GM 17.8%
FCFM 3.63%
ROA(3y)1.76%
ROA(5y)4.56%
ROE(3y)3.55%
ROE(5y)8.83%
ROIC(3y)2.66%
ROIC(5y)4.13%
ROICexc(3y)3.19%
ROICexc(5y)5.03%
ROICexgc(3y)6.48%
ROICexgc(5y)9.7%
ROCE(3y)4.96%
ROCE(5y)7.74%
ROICexgc growth 3Y-32.65%
ROICexgc growth 5Y-8.51%
ROICexc growth 3Y-33.65%
ROICexc growth 5Y-10.69%
OM growth 3Y-28.32%
OM growth 5Y-8.39%
PM growth 3Y-62.59%
PM growth 5Y-35.51%
GM growth 3Y-7.29%
GM growth 5Y-1.94%
F-Score6
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 13.85
Debt/EBITDA 3.02
Cap/Depr 79.71%
Cap/Sales 7.37%
Interest Coverage 17.5
Cash Conversion 79.25%
Profit Quality 843.59%
Current Ratio 2.13
Quick Ratio 1.63
Altman-Z 1.76
F-Score6
WACC4.67%
ROIC/WACC0.41
Cap/Depr(3y)89.68%
Cap/Depr(5y)93.13%
Cap/Sales(3y)7.49%
Cap/Sales(5y)7.36%
Profit Quality(3y)365.95%
Profit Quality(5y)238.07%
High Growth Momentum
Growth
EPS 1Y (TTM)-47.5%
EPS 3Y-34.91%
EPS 5Y-3.31%
EPS Q2Q%-66.14%
EPS Next Y14.19%
EPS Next 2Y16.67%
EPS Next 3Y15.04%
EPS Next 5Y11.99%
Revenue 1Y (TTM)-4.99%
Revenue growth 3Y-7.75%
Revenue growth 5Y2.84%
Sales Q2Q%-7.39%
Revenue Next Year0.21%
Revenue Next 2Y1.55%
Revenue Next 3Y1.99%
Revenue Next 5Y2.68%
EBIT growth 1Y-41.5%
EBIT growth 3Y-33.87%
EBIT growth 5Y-5.79%
EBIT Next Year131.92%
EBIT Next 3Y38.79%
EBIT Next 5Y24.49%
FCF growth 1Y-8.61%
FCF growth 3Y-24.55%
FCF growth 5Y-8.39%
OCF growth 1Y-11.06%
OCF growth 3Y-12.65%
OCF growth 5Y-2.21%

ARKEMA / AKE.PA Fundamental Analysis FAQ

What is the fundamental rating for AKE stock?

ChartMill assigns a fundamental rating of 4 / 10 to AKE.PA.


Can you provide the valuation status for ARKEMA?

ChartMill assigns a valuation rating of 7 / 10 to ARKEMA (AKE.PA). This can be considered as Undervalued.


Can you provide the profitability details for ARKEMA?

ARKEMA (AKE.PA) has a profitability rating of 3 / 10.


What are the PE and PB ratios of ARKEMA (AKE.PA) stock?

The Price/Earnings (PE) ratio for ARKEMA (AKE.PA) is 14.12 and the Price/Book (PB) ratio is 0.68.


Can you provide the financial health for AKE stock?

The financial health rating of ARKEMA (AKE.PA) is 4 / 10.